Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2024
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough TherapiesJaleh Fallah, Flora Mulkey, Mallorie H Fiero, et al.JCO Precision Oncology|August 29, 2024
False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring <i>ATM</i> and <i>CHEK2</i> MutationsJaleh Fallah, Jianjin Xu, Hee-Koung Joeng, et al.BMC Medical Research Methodology|August 8, 2025
Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignanciesGita Thanarajasingam, Vishal Bhatnagar, Brie N Noble, et al.The Lancet. Oncology|May 4, 2023
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practiceLimin Liu, Jungyeon Choi, Jammbe Z Musoro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2025
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian CancerMirat Shah, Ting-Yu Chen, Gwynn Ison, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate CancerJaleh Fallah, Sundeep Agrawal, Haley Gittleman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2021
FDA Approval Summary: Tivozanib for Relapsed or Refractory Renal Cell CarcinomaElaine Chang, Chana Weinstock, Lijun Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2024
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial CarcinomaMichael H Brave, William F Maguire, Chana Weinstock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
FDA Approval Summary: Accelerated Approval of Sacituzumab Govitecan-hziy for Third-line Treatment of Metastatic Triple-negative Breast CancerSakar Wahby, Lola Fashoyin-Aje, Christy L Osgood, et al.BMJ Open|January 10, 2024
Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort studyGita Thanarajasingam, Paul Kluetz, Vishal Bhatnagar, et al.Pageof 5